Related Experiment Videos

Local anesthetic-induced toxicity may be modified by low doses of flumazenil

B Bruguerolle1, N Emperaire

  • 1Laboratoire de Pharmacologie Médicale, Faculté de Médecine de Marseille, France.

Life Sciences
|January 1, 1992
PubMed

Insights

Flumazenil did not alter local anesthetic-induced mortality in mice. However, flumazenil increased the convulsant activity of lidocaine and mepivacaine, while decreasing the onset time for lidocaine convulsions.

Area of Science:

  • Pharmacology
  • Toxicology
  • Neuroscience

Context:

  • Local anesthetics are widely used for pain management.
  • Acute toxicity, including seizures and cardiovascular collapse, can occur with high doses.
  • Flumazenil is a benzodiazepine receptor antagonist.

Purpose:

  • To determine the effect of flumazenil on the acute toxicity of etidocaine, mepivacaine, and lidocaine in a mouse model.
  • To assess flumazenil's influence on mortality, convulsant activity, and latency to convulsions.

Summary:

  • Mice received varying doses of flumazenil or saline before anesthetic injection.
  • Flumazenil did not significantly affect the mortality rates induced by the tested local anesthetics.
  • Flumazenil significantly enhanced the convulsant activity of lidocaine and mepivacaine, but not etidocaine.
  • Increasing flumazenil doses reduced the latency to lidocaine-induced convulsions.

Impact:

  • Flumazenil may potentiate the central nervous system side effects of certain local anesthetics like lidocaine and mepivacaine.
  • Findings suggest careful consideration when using flumazenil in patients experiencing toxicity from these specific local anesthetics.
  • Further research is needed to elucidate the mechanisms underlying flumazenil's pro-convulsant effects with certain anesthetics.

Related Concept Videos